Kauhanen S, Seppänen M, Ovaska J, Minn H, Bergman J, Korsoff P, et al. The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors. Endocr Relat Cancer. 2009;16:255–65.

Article  CAS  PubMed  Google Scholar 

Bozkurt MF, Virgolini I, Balogova S, Beheshti M, Rubello D, Decristoforo C, et al. Guideline for PET/CT imaging of neuroendocrine neoplasms with (68)Ga-DOTA-conjugated somatostatin receptor targeting peptides and (18)F-DOPA. Eur J Nucl Med Mol Imaging. 2017;44:1588–601.

Article  CAS  PubMed  Google Scholar 

Giovanella L, Treglia G, Iakovou I, Mihailovic J, Verburg FA, Luster M. EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2020;47:61–77.

Article  PubMed  Google Scholar 

Taïeb D, Hicks RJ, Hindié E, Guillet BA, Avram A, Ghedini P, et al. European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2019;46:2112–37.

Article  PubMed  PubMed Central  Google Scholar 

Law I, Albert NL, Arbizu J, Boellaard R, Drzezga A, Galldiks N, et al. Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [(18)F]FDG: version 1.0. Eur J Nucl Med Mol Imaging. 2019;46:540–57.

Article  CAS  PubMed  Google Scholar 

Technical standards for diagnostic procedures using radiopharmaceuticals. Korean Society of Nuclear Medicine; 2014.

Neves ÂCB, Hrynchak I, Fonseca I, Alves VHP, Pereira MM, Falcão A, et al. Advances in the automated synthesis of 6-[(18)F]Fluoro-L-DOPA. EJNMMI Radiopharm Chem. 2021;6:11.

Article  PubMed  PubMed Central  Google Scholar 

Minn H, Kauhanen S, Seppänen M, Nuutila P. 18F-FDOPA: a multiple-target molecule. J Nucl Med. 2009;50:1915–8.

Article  CAS  PubMed  Google Scholar 

Koopmans K, Ziekenhuis M, Eshuis GS. 18F DOPA PET/CT in neuroendocrine tumours and in presynaptic dopaminergic deficits. 2017

Balogova S, Talbot JN, Nataf V, Michaud L, Huchet V, Kerrou K, et al. 18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type. Eur J Nucl Med Mol Imaging. 2013;40:943–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tessonnier L, Sebag F, Ghander C, De Micco C, Reynaud R, Palazzo FF, et al. Limited value of 18F-F-DOPA PET to localize pancreatic insulin-secreting tumors in adults with hyperinsulinemic hypoglycemia. J Clin Endocrinol Metab. 2010;95:303–7.

Article  CAS  PubMed  Google Scholar 

Kauhanen S, Seppänen M, Nuutila P. Premedication with carbidopa masks positive finding of insulinoma and beta-cell hyperplasia in [(18)F]-dihydroxy-phenyl-alanine positron emission tomography. J Clin Oncol. 2008;26:5307–8. author reply 8–9.

Article  PubMed  Google Scholar 

Imperiale A, Sebag F, Vix M, Castinetti F, Kessler L, Moreau F, et al. 18F-FDOPA PET/CT imaging of insulinoma revisited. Eur J Nucl Med Mol Imaging. 2015;42:409–18.

Article  CAS  PubMed  Google Scholar 

Kauhanen S, Seppänen M, Minn H, Nuutila P. Clinical PET imaging of insulinoma and beta-cell hyperplasia. Curr Pharm Des. 2010;16:1550–60.

Article  CAS  PubMed  Google Scholar 

Lu MY, Liu YL, Chang HH, Jou ST, Yang YL, Lin KH, et al. Characterization of neuroblastic tumors using 18F-FDOPA PET. J Nucl Med. 2013;54:42–9.

Article  CAS  PubMed  Google Scholar 

Fiz F, Bini F, Gabriele E, Bottoni G, Garrè ML, Marinozzi F, et al. Role of Dynamic Parameters of 18F-DOPA PET/CT in Pediatric Gliomas. Clin Nucl Med. 2022;47:517–24.

Article  PubMed  Google Scholar 

Taïeb D, Timmers HJ, Hindié E, Guillet BA, Neumann HP, Walz MK, et al. EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2012;39:1977–95.

Article  PubMed  PubMed Central  Google Scholar 

Chondrogiannis S, Marzola MC, Al-Nahhas A, Venkatanarayana TD, Mazza A, Opocher G, et al. Normal biodistribution pattern and physiologic variants of 18F-DOPA PET imaging. Nucl Med Commun. 2013;34:1141–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Adams MC, Turkington TG, Wilson JM, Wong TZ. A systematic review of the factors affecting accuracy of SUV measurements. AJR Am J Roentgenol. 2010;195:310–20.

Article  PubMed  Google Scholar 

Niederkohr RD, Greenspan BS, Prior JO, Schöder H, Seltzer MA, Zukotynski KA, et al. Reporting guidance for oncologic 18F-FDG PET/CT imaging. J Nucl Med. 2013;54:756–61.

Article  CAS  PubMed  Google Scholar 

Guidelines on quality control. procedures and measurement methods for PET and PET/CT. Korean Society of Nuclear Medicine; 2020.

Infection control and prevention in healthcare facilities. (5th edition). Korean Society for Healthcare-associated Infection Control and Prevention. Hanmi medical publishing company; 2017.